Clinical Trial Update: Study Combining Zevalin With High-Dose Chemotherapy Prior to Autologous StemCell Transplant in Patients With Relapsed, Refractory, or Transformed Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

This document reports on a Phase 2 clinical trial evaluating the combination of Zevalin with high-dose chemotherapy before autologous stem cell transplantation …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Zevalin (ibritumomab tiuxetan)

Snippet

Sponsor: McGill University | Conditions: Non-Hodgkin's Lymphoma | Phase 2 | Status: UNKNOWN